Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New topoisomerase I inhibitors synthesized at Rutgers

Jan. 13, 1997

New manumycin-class antibiotics isolated at Tanabe Seiyaku

Jan. 10, 1997

Antileukemic bisabolane sesquiterpene isolated from natural sources

Jan. 10, 1997

Three new melanoma vaccines from Therion Biologics enter clinical testing

Jan. 9, 1997

QLT, AHP redefine Photofrin relationship

Jan. 9, 1997

Progress in Sugen's cancer development pipeline

Jan. 9, 1997

OXiGENE and Boston Medical Center announce collaboration

Jan. 9, 1997

Vion receives SBIR grant to develop ribonucleotide reductase inhibitor

Jan. 9, 1997

KGF receptor antagonists developed by U.S. researchers

Jan. 9, 1997

BCH-4556 slated to enter clinical testing

Jan. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...